/wp-content/uploads/candel_logo.svg00cchan@candeltx.com/wp-content/uploads/candel_logo.svgcchan@candeltx.com2021-04-13 05:04:502021-04-13 08:29:03Candel Therapeutics Announces Formation of New Research Advisory Board Comprised of Multiple Prominent Scientists and Clinicians including 2018 Nobel Laureate, James Allison, Ph.D.
/wp-content/uploads/candel_logo.svg00cchan@candeltx.com/wp-content/uploads/candel_logo.svgcchan@candeltx.com2021-04-09 05:02:342021-04-09 05:02:34Candel Therapeutics Appoints Chris Matheny, PharmD, Ph.D., as Vice President, Development Leader
/wp-content/uploads/candel_logo.svg00David Anderson/wp-content/uploads/candel_logo.svgDavid Anderson2020-12-08 08:00:532020-12-08 08:00:53Candel Therapeutics Appoints Pharma Veteran and Immunologist Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer; Expands Leadership Team With Chief Financial Officer, Chief Business Officer and Chief Regulatory Officer Appointments
/wp-content/uploads/candel_logo.svg00David Anderson/wp-content/uploads/candel_logo.svgDavid Anderson2020-05-30 08:00:392020-05-30 08:00:39Candel Therapeutics Announces Presentation of Clinical Data for GMCI in NSCLC at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting
/wp-content/uploads/candel_logo.svg00David Anderson/wp-content/uploads/candel_logo.svgDavid Anderson2020-05-18 08:00:012020-05-18 08:00:01Candel Therapeutics Announces Presentation at the 2020 American Society of Gene and Cell Therapy (ASGCT) 23rd Annual Meeting
/wp-content/uploads/candel_logo.svg00David Anderson/wp-content/uploads/candel_logo.svgDavid Anderson2020-01-08 08:00:542020-01-08 08:00:54Candel Therapeutics acquires next-generation herpes drug development platform and manufacturing expertise
Candel Therapeutics Announces Formation of New Research Advisory Board Comprised of Multiple Prominent Scientists and Clinicians including 2018 Nobel Laureate, James Allison, Ph.D.
Press ReleaseCandel Therapeutics Appoints Chris Matheny, PharmD, Ph.D., as Vice President, Development Leader
Press ReleaseCandel Therapeutics Appoints Pharma Veteran and Immunologist Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer; Expands Leadership Team With Chief Financial Officer, Chief Business Officer and Chief Regulatory Officer Appointments
Press ReleaseCandel Therapeutics Announces Presentation of Clinical Data for GMCI in NSCLC at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting
Press ReleaseCandel Therapeutics Announces Presentation at the 2020 American Society of Gene and Cell Therapy (ASGCT) 23rd Annual Meeting
Press ReleaseCandel Therapeutics acquires next-generation herpes drug development platform and manufacturing expertise
Press Release